Document Detail

Enfurvitide prevents vertical transmission of multidrug-resistant HIV-1 in pregnancy but does not cross the placenta.
MedLine Citation:
PMID:  16511429     Owner:  NLM     Status:  MEDLINE    
The use of previously successful antiretroviral regimens in mother-to-child transmission (MTCT) prevention will be increasingly challenged by the rising prevalence of multidrug-resistant (MDR) HIV. We used enfurvitide together with an optimized antiretroviral backbone to prevent the MTCT prevention of MDR HIV in two pregnant women. The measurement of maternal and foetal peripheral blood levels of enfurvitide showed no evidence of transplacental transfer.
Paul Brennan-Benson; Mark Pakianathan; Philip Rice; Stefano Bonora; Rana Chakraborty; Michael Sharland; Phillip Hay
Related Documents :
12512929 - Mass treatment with nevirapine to prevent mother-to-child transmission of hiv/aids in s...
9240849 - Interaction between timing of perinatal human immunodeficiency virus infection and the ...
11160699 - Mucosal transmission and induction of simian aids by ccr5-specific simian/human immunod...
19067479 - Modelling the impact of artemisinin combination therapy and long-acting treatments on m...
14600529 - The effects of placental malaria on mother-to-child hiv transmission in rakai, uganda.
15467579 - Elective cesarean delivery to prevent perinatal transmission of hepatitis c virus: a co...
12118949 - Influence of helicobacter pylori infection on severity of oesophagitis and response to ...
22169719 - Il-21 level in chinese hiv infected individuals and its dynamics undergoing haart.
20207669 - Inmates with hiv, stigma, and disclosure decision-making.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  AIDS (London, England)     Volume:  20     ISSN:  0269-9370     ISO Abbreviation:  AIDS     Publication Date:  2006 Jan 
Date Detail:
Created Date:  2006-03-02     Completed Date:  2006-12-07     Revised Date:  2013-11-25    
Medline Journal Info:
Nlm Unique ID:  8710219     Medline TA:  AIDS     Country:  England    
Other Details:
Languages:  eng     Pagination:  297-9     Citation Subset:  IM; X    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug Resistance, Multiple, Viral
HIV Envelope Protein gp41 / therapeutic use*
HIV Fusion Inhibitors / pharmacokinetics,  therapeutic use
HIV Infections / drug therapy*,  transmission
HIV-1 / drug effects*
Infectious Disease Transmission, Vertical / prevention & control*
Maternal-Fetal Exchange
Peptide Fragments / pharmacokinetics,  therapeutic use*
Pregnancy Complications, Infectious / drug therapy*
Reg. No./Substance:
0/HIV Envelope Protein gp41; 0/HIV Fusion Inhibitors; 0/Peptide Fragments; 19OWO1T3ZE/enfuvirtide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophyl...
Next Document:  Incidence rates of hospitalization related to traumatic brain injury--12 states, 2002.